Published in Vaccine Weekly, July 25th, 2007
The 42-week study (NAWI1618-07-01) uses 10 groups of BALB/C...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.